#jubilantingrevia has multiple growth triggers during the current financial year and over the next 2-3 years! #PatienceYoga 🧘🏻♂️
More from Jubliantingrevia
Its an extremely informative AR with broad industry & segment wise overview. MUST READ
Lot of moving parts but looks very optimistic & strong growth outlook.
https://t.co/MxuTZDUfFT
https://t.co/ejcXEAQTHH
#JubilantIngrevia Planned Capex of Rs. 900 Cr. in next 3 yrs.
— Mouzam (@mmali09) March 30, 2021
Entry into Diketene derivatives -game changer.
- Import substitution opp. (40% is imported)
- used in Pharma & Agro Chem
- currently at 50% discount to competitor in India
- one of the leading Int. supplier Exit https://t.co/etPtndC1xN pic.twitter.com/WRQUFXHAtR
https://t.co/7YanRjNE8i
#JubilantIngrevia
— Mouzam (@mmali09) June 24, 2021
\U0001f44cAcquisition of 385,100 equity shares worth Rs 21.36 Cr by the promoter group.
Promoter buying is a Big Positive\U0001f3af
Shows that he is confident about its prospects and believes that investing in the company is better than putting money somewhere else.\U0001f4aa\U0001f4c8 https://t.co/vNYcSr3RgV pic.twitter.com/0WnXGN0UYZ
https://t.co/IW0GRBXi7h
#JUBLINGREA
— Mouzam (@mmali09) July 20, 2021
Super Result\U0001f680QoQ/YoY
Despite covid issues
YoY
Rev 1145Cr vs 737cr (+55%)
EBTDA 25% vs 17%
PAT 168cr vs 53cr (+220%)
EPS 10.6 vs 3.3
\U0001f525All 3 engines
\U0001f9eaInteresting Key CAPEX:
- Dietene on schedule
- CDMO GMP - new
- 2 Multipurpose Spl. Chemical plants new https://t.co/vNYcSr3RgV pic.twitter.com/0rcmB1YMfM
https://t.co/GqcV0GbaLD
Bio-Acetaldehyde - Bio based \U0001f9ec, World\u2019s largest manufacturer from \U0001f1ee\U0001f1f3
— Punit (@punitbansal14) July 28, 2021
Image 1: Benefit in carbon footprint as compared to the conventional petroleum route
Image 2: Bio-Acetaldehyde business overview pic.twitter.com/7M2Eqz5maS
You May Also Like
1 - open trading view in your browser and select stock scanner in left corner down side .
2 - touch the percentage% gain change ( and u can see higest gainer of today)
Making thread \U0001f9f5 on trading view scanner by which you can select intraday and btst stocks .
— Vikrant (@Trading0secrets) October 22, 2021
In just few hours (Without any watchlist)
Some manual efforts u have to put on it.
Soon going to share the process with u whenever it will be ready .
"How's the josh?"guys \U0001f57a\U0001f3b7\U0001f483
3. Then, start with 6% gainer to 20% gainer and look charts of everyone in daily Timeframe . (For fno selection u can choose 1% to 4% )
4. Then manually select the stocks which are going to give all time high BO or 52 high BO or already given.
5. U can also select those stocks which are going to give range breakout or already given range BO
6 . If in 15 min chart📊 any stock sustaing near BO zone or after BO then select it on your watchlist
7 . Now next day if any stock show momentum u can take trade in it with RM
This looks very easy & simple but,
U will amazed to see it's result if you follow proper risk management.
I did 4x my capital by trading in only momentum stocks.
I will keep sharing such learning thread 🧵 for you 🙏💞🙏
Keep learning / keep sharing 🙏
@AdityaTodmal
Always. No, your company is not an exception.
A tactic I don’t appreciate at all because of how unfairly it penalizes low-leverage, junior employees, and those loyal enough not to question it, but that’s negotiation for you after all. Weaponized information asymmetry.
Listen to Aditya
"we don't negotiate salaries" really means "we'd prefer to negotiate massive signing bonuses and equity grants, but we'll negotiate salary if you REALLY insist" https://t.co/80k7nWAMoK
— Aditya Mukerjee, the Otterrific \U0001f3f3\ufe0f\u200d\U0001f308 (@chimeracoder) December 4, 2018
And by the way, you should never be worried that an offer would be withdrawn if you politely negotiate.
I have seen this happen *extremely* rarely, mostly to women, and anyway is a giant red flag. It suggests you probably didn’t want to work there.
You wish there was no negotiating so it would all be more fair? I feel you, but it’s not happening.
Instead, negotiate hard, use your privilege, and then go and share numbers with your underrepresented and underpaid colleagues. […]